期刊文献+

植物来源的胰脂肪酶抑制剂研究进展 被引量:3

Research Advances in Pancreatic Lipase Inhibitors from Plants
下载PDF
导出
摘要 可食植物来源的活性成分具有毒性低、生物特性多样的特点,从中寻找具有显著功效的有效部位和成分一直是功能性食品等健康产品研发的重要来源。近年来从植物中发现了多种对胰脂肪酶(pancreatic lipase,PL)有显著抑制活性的有效成分。这些成分通过抑制PL的活性可减少人体消化系统对摄入食品中脂肪成分的吸收程度,在肥胖、高脂血症等疾病的辅助治疗上显示了良好的效果。基于此,该文综述近年来植物来源的胰脂肪酶抑制剂研究进展。 Active ingredients derived from plants,especially edible plants are characterized by low toxicity and diverse biological characteristics. Finding effective parts/ingredients with significant efficacy has always been an important source of research and development of health products such as drugs and functional foods. In recent years,a variety of effective components have been found in plants that have significant inhibitory activities against pancreatic lipase(PL). By inhibiting the activity of PL,these components can reduce the absorption degree of fat components in the ingested food in the digestive system of the human body,showing good effects in the adjuvant treatment of obesity,hyperlipidemia and other diseases. Based on this,this paper reviews the research progress of plant derived pancreatic lipase inhibitors in recent years.
作者 郭子雨 姚雨含 刘涛 赵军 GUO Zi-yu;YAO Yu-han;LIU Tao;ZHAO Jun(College of Life Sciences&Technology,Xinjiang University,Urumqi 830046,Xinjiang,China;Xinjiang Key Laboratory for Uighur Medicines,Xinjiang Institute of Materia Medica,Urumqi 830004,Xinjiang,China;College of Public Health,Xinjiang Medical University,Urumqi 830011,Xinjiang,China)
出处 《食品研究与开发》 CAS 北大核心 2021年第8期212-217,共6页 Food Research and Development
关键词 胰脂肪酶抑制剂 肥胖症治疗 天然产物 中药活性成分 高血脂 pancreatic lipase inhibitor obesity treatment natural products active ingrediengts of traditional Chinese medicine hyperlipidemia
  • 相关文献

参考文献3

二级参考文献34

  • 1Kopelman P G.Obesity as a medical problem[J].Nature,2000,404:635.
  • 2Mooradian A D.Obesity:a rational target for managing diabetesmellitus[J].Growth Horm IGF Res,2001,11:S79.
  • 3Alemany M,Remesar X,Fernández-López J-A.Drug strategiesfor the treatment of obesity[J].IDrugs,2003,6:566.
  • 4J L Chiasson,R G Josse,R Gomis,et al.Acarbose for preven-tion of type 2 diabetes mellitus:the STOP-NIDDM randomisedtrial[J].Lancet,2002,359:2072.
  • 5Sugiyama H,Shoji T,Yamaguchi,A,et al.Oligomeric procya-nidins in apple polyphenol are main active components for inhibi-tion of pancreatic lipase&triglyceride absorption[J].J AgricFood Chem,2007,55(1),4604.
  • 6Oki T,Matsui T,Osajima,Y.Inhibitory effect of a-glucosidaseinhibitors varies according to its origin[J].J Agric Food Chem,1999,47,550.
  • 7Stumoll M,Haring H.Insulin resistance and insulin sensitizers[J].Horm Res,2001,55(2):3.
  • 8Ballinger A,Peikin S R.Orlistat:its current status as an anti-obesity drug[J].Eur J Pharmacol,2002,440:109.
  • 9Chao E C.A paradigm shift in diabetes therapy-dapagliflozin andother SGLT2 inhibitors[J].Discov Med,2011,11(58):255.
  • 10Strojek K,Yoon K,Hruba V,et al.Effect of dapagliflozin in pa-tients with type 2 diabetes who have inadequate glycaemic controlwith glimepiride:a randomised,24-week,doubleblind,placebo-controlled trial[J].Diabetes Obes Metab,2011,13(10):928.

共引文献22

同被引文献57

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部